| No headlines available for THBFX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 3.34M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 6.86% | | 5y Avg Return: | 1.76% | | Rank in Category (ytd): | 141 | | % Rank in Category (ytd): | 85.45% | | Beta (3y): | 0.68 | | Morningstar Risk Rating: | Below average |
|
| The investment seeks long term capital appreciation. The funds invests at least 80% of assets in common stocks of healthcare and biotechnology companies that are traded in the U.S.. It typically invests in the common stocks of medium to large capitalization companies, but may also invest in companies of any size. These securities may be traded over the counter or listed on an exchange. The fund may engage in frequent and active trading of securities. It is nondiversified. | | | Fund Profile |
|
Help
0.10 (0.79%) 
Summary
Add THBFX to Portfolio 
Download Data
